Title : Possible metformin-induced hepatotoxicity.

Pub. Date : 2005 Dec

PMID : 16503324






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Metformin hydrochloride is widely used for the treatment of type 2 diabetes mellitus (DM-2). Metformin immunoglobulin heavy diversity 1-14 (non-functional) Homo sapiens
2 OBJECTIVE: The aim of this article was to report a case of serious hepatotoxicity possibly associated with metformin use in an elderly patient with DM-2. Metformin immunoglobulin heavy diversity 1-14 (non-functional) Homo sapiens
3 METHODS: After receiving metformin 500 mg/d for 3 weeks, a 73-year-old Japanese woman weighing 33.5 kg with poorly controlled DM-2 presented with fatigue, jaundice, nausea, vomiting, anorexia, and abdominal pain. Metformin immunoglobulin heavy diversity 1-14 (non-functional) Homo sapiens
4 CONCLUSIONS: In this case of an elderly woman with DM-2 who presented with symptoms of hepatotoxicity after 3 weeks of metformin treatment, metformin appeared to have caused a mixed-type (hepatocellular and cholestatic) hepatic damage. Metformin immunoglobulin heavy diversity 1-14 (non-functional) Homo sapiens
5 CONCLUSIONS: In this case of an elderly woman with DM-2 who presented with symptoms of hepatotoxicity after 3 weeks of metformin treatment, metformin appeared to have caused a mixed-type (hepatocellular and cholestatic) hepatic damage. Metformin immunoglobulin heavy diversity 1-14 (non-functional) Homo sapiens